Drug-Coated Balloon Coronary Angioplasty Versus Stenting for Treatment of Disease Adjacent to a Chronic Total Occlusion.

Inclusion Criteria: * Age ≥ 18 years * Clinical indication for revascularization of the CTO as determined by the local heart team (based on symptoms, documented ischemia, and viability) * Successful recanalization of the CTO with residual disease adjacent to the initial lesion Exclusion Criteria: * Dissection affecting the flow (TIMI score\<3), significant recoil (\>30%) or coronary perforation after predilation * Reference diameter of the vessel is \<2.5 mm or \>4.0 mm * Bifurcation lesion requiring the stenting of the side branch * Left main lesion * Acute coronary syndrome * Cardiogenic shock * Severe kidney disease defined as an eGFR \< 30 ml/min * Pregnancy * Life expectancy \< 12 months * Inability to give written consent